Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm

Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm

Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kachestvennai͡a︡ klinicheskai͡a︡ praktika 2020-10 (4S), p.11-14
Hauptverfasser: Otdelenov, V. A., Tsvetov, V. M., Sychev, D. A.
Format: Artikel
Sprache:eng
Schlagworte:
covid-19
барицитиниб
коронавирус
цитокиновый шторм
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.
ISSN:2588-0519
2618-8473
DOI:10.37489/2588-0519-2020-S4-11-14